These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 650355)

  • 1. The effect of 1,25(OH)2 vitamin D3 supplementation in premature infants.
    Chan GM; Tsang RC; Chen IW; DeLuca HF; Steichen JJ
    J Pediatr; 1978 Jul; 93(1):91-6. PubMed ID: 650355
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 1.25 dihydroxycholecalciferol on calcium phosphorus and magnesium balance in preterm infants.
    Senterre J; David L; Salle B
    Ann Endocrinol (Paris); 1979; 40(2):163-4. PubMed ID: 475308
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
    Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term.
    Fleischman AR; Rosen JF; Cole J; Smith CM; Deluca HF
    J Pediatr; 1980 Oct; 97(4):640-2. PubMed ID: 6968348
    [No Abstract]   [Full Text] [Related]  

  • 5. 25-Hydroxycholecalciferol for early neonatal hypocalcemia. Occurrence in premature newborns.
    Fleischman AR; Rosen JF; Nathenson G
    Am J Dis Child; 1978 Oct; 132(10):973-7. PubMed ID: 717307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients.
    Lund B; Andersen RB; Friis T; Hjorth L; Jørgensen FS; Norman AW; Sørensen OH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():177s-181s. PubMed ID: 606415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of early neonatal hypocalcemia in low birth weight infants with continuous calcium infusion: effect on serum calcium, phosphorus, magnesium, and circulating immunoreactive parathyroid hormone and calcitonin.
    Salle BL; David L; Chopard JP; Grafmeyer DC; Renaud H
    Pediatr Res; 1977 Dec; 11(12):1180-5. PubMed ID: 593762
    [No Abstract]   [Full Text] [Related]  

  • 8. Early neonatal hypocalcemia in extremely preterm infants. High incidence, early onset, and refractoriness to supraphysiologic doses of calcitriol.
    Venkataraman PS; Tsang RC; Steichen JJ; Grey I; Neylan M; Fleischman AR
    Am J Dis Child; 1986 Oct; 140(10):1004-8. PubMed ID: 3755862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D metabolism in preterm infants: effect of a calcium load.
    Delvin EE; Salle BL; Glorieux FH; David LS
    Biol Neonate; 1988; 53(6):321-6. PubMed ID: 3408750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 12. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of protracted neonatal hypocalcaemia to 1alpha,25-dihydroxyvitamin D3.
    Kooh SW; Fraser D; Toon R; DeLuca HF
    Lancet; 1976 Nov; 2(7995):1105-7. PubMed ID: 62947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
    Coburn JW; Brickman AS
    Adv Exp Med Biol; 1978; 103():473-86. PubMed ID: 362852
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P; Zingraff J; Gueris J; Jungers P; Marie P; Pechet M; Rasmussen H
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
    Brickman AS; Coburn JW; Norman AW; Massry SG
    Am J Med; 1974 Jul; 57(1):28-33. PubMed ID: 4600292
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
    Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
    J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocalcemia in infants of diabetic mothers. Studies in circulating calciotropic hormone concentrations.
    Salle B; David L; Glorieux F; Delvin EE; Louis JJ; Troncy G
    Acta Paediatr Scand; 1982 Jul; 71(4):573-7. PubMed ID: 7136673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.